Trial Profile
Clinical Trials Insight: 700039857
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 Dec 2008
Price :
$35
*
At a glance
- Drugs Elafibranor (Primary)
- Indications Diabetes mellitus; Dyslipidaemias; Obesity
- Focus Adverse reactions
- 17 Dec 2008 "Efficacy" results reported in a Genfit media release.
- 18 Nov 2008 Tolerability results reported in a Genfit media release.
- 18 Nov 2008 New trial record.